{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:30:52Z","timestamp":1791181852624,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.arcmed.2007.07.009","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T11:07:07Z","timestamp":1196939227000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["The 677 C\/T MTHFR Polymorphism is Associated with Essential Hypertension, Coronary Artery Disease, and Higher Homocysteine Levels"],"prefix":"10.1016","volume":"39","author":[{"given":"Nevin","family":"Ilhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kucuksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Kaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necip","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilmaz","family":"Ozbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2007.07.009_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00041433-199812000-00004","article-title":"Recent data are not in conflict with homocysteine as a cardiovascular risk factor","volume":"9","author":"Refsum","year":"1998","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arcmed.2007.07.009_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0895-7061(99)00138-7","article-title":"Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects","volume":"13","author":"Sheu","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2007.07.009_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/bj3320213","article-title":"Characterization of the stress-inducing effects of homocysteine","volume":"332","author":"Outinen","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.arcmed.2007.07.009_bib4","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","article-title":"Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase","volume":"272","author":"Upchurch","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.07.009_bib5","first-page":"1764","article-title":"Total homocysteine in plasma or serum: methods and and clinical applications","volume":"93","author":"Ueland","year":"1993","journal-title":"Clin Biochem"},{"key":"10.1016\/j.arcmed.2007.07.009_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s004390050776","article-title":"MTHFR association with atherosclerotic vascular disease?","volume":"103","author":"Fletcher","year":"1998","journal-title":"Hum Genet"},{"key":"10.1016\/j.arcmed.2007.07.009_bib7","first-page":"1751","article-title":"Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia","volume":"20","author":"Piyathilake","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.arcmed.2007.07.009_bib8","first-page":"3272","article-title":"Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population","volume":"61","author":"Song","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2007.07.009_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nature Genet"},{"key":"10.1016\/j.arcmed.2007.07.009_bib10","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2337\/diacare.23.9.1348","article-title":"Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents","volume":"23","author":"Gallistl","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2007.07.009_bib11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/aje\/kwf157","article-title":"Homocysteine and blood pressure in the third national health and nutrition examination survey, 1988\u20131994","volume":"156","author":"Lim","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arcmed.2007.07.009_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","article-title":"Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study","volume":"274","author":"Nygard","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2007.07.009_bib13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.CIR.96.6.1745","article-title":"High homocysteine levels are independently related to isolated systolic hypertension in older adults","volume":"96","author":"Sutton-Tyrrell","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2007.07.009_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.HYP.34.4.837","article-title":"Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients","volume":"34","author":"Bortolotto","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.arcmed.2007.07.009_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0895-7061(02)02984-9","article-title":"Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins","volume":"15","author":"Kahleova","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2007.07.009_bib16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.arcmed.2007.07.009_bib17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/01.STR.0000075769.09092.82","article-title":"Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population","volume":"34","author":"Inamoto","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.arcmed.2007.07.009_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:THRO.0000040489.86029.27","article-title":"Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease","volume":"17","author":"Almawi","year":"2004","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.arcmed.2007.07.009_bib19","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.95.8.2032","article-title":"Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease","volume":"95","author":"Morita","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2007.07.009_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9150(00)00389-0","article-title":"The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations","volume":"153","author":"Jee","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2007.07.009_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.ATV.16.7.878","article-title":"Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation","volume":"16","author":"Wilcken","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2007.07.009_bib22","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/01.CIR.94.10.2410","article-title":"Methylenetetrahydrofolate polymorphism, plasma folate, homocysteine, and risk of myocordias infarction in US physicians","volume":"94","author":"Ma","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2007.07.009_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9150(01)00699-2","article-title":"Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters","volume":"162","author":"Rothenbacher","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2007.07.009_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0009-8981(03)00283-3","article-title":"Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groups","volume":"335","author":"Zuntar","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2007.07.009_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijcard.2003.08.021","article-title":"The methylenetetrahydrofolate reductase gene polymorphism (C677T) is associated with increased cardiovascular mortality in Hungary","volume":"97","author":"Kalina","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arcmed.2007.07.009_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/hrt.81.5.518","article-title":"Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate","volume":"81","author":"Tokgozoglu","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.arcmed.2007.07.009_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0049-3848(01)00226-2","article-title":"Common mutations at the homocysteine metabolism pathway and pediatric stroke","volume":"102","author":"Akar","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2007.07.009_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cbf.1206","article-title":"C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease","volume":"24","author":"Yilmaz","year":"2006","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.arcmed.2007.07.009_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0049-3848(01)00278-X","article-title":"Mutations in the genes regulating methylenetetrahydrofolate reductase (MTHFR CYT677) and cystathione beta-synthase (CBS GYA919, CBS TYc833) are not associated with myocardial infarction in African Americans","volume":"103","author":"Dilley","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2007.07.009_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0037-1615053","article-title":"The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD)","volume":"79","author":"Abbate","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2007.07.009_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","article-title":"The controversy over homocysteine and cardiovascular risk","volume":"72","author":"Ueland","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2007.07.009_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: cause or effect?","volume":"72","author":"Brattstrom","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2007.07.009_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archinte.160.4.422","article-title":"Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?","volume":"160","author":"Christen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arcmed.2007.07.009_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/oxfordjournals.aje.a008798","article-title":"Lowered risks of hypertension and cerebrovascular disease after vitamin\/mineral supplementation: the Linxian Nutrition Intervention Trial","volume":"143","author":"Mark","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arcmed.2007.07.009_bib35","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMoa011364","article-title":"Decreased rate of coronary restenosis after lowering of plasma homocysteine levels","volume":"345","author":"Schnyder","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2007.07.009_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart Study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2007.07.009_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/mgme.2001.3188","article-title":"Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population","volume":"73","author":"Benes","year":"2001","journal-title":"J Mol Genet Metab"},{"key":"10.1016\/j.arcmed.2007.07.009_bib38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/338932","article-title":"The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans","volume":"70","author":"Rosenberg","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2007.07.009_bib39","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood.V91.11.4158","volume":"91","author":"Girelli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2007.07.009_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(97)00084-1","article-title":"The 677C>T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease","volume":"132","author":"Verhoef","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2007.07.009_bib41","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1161\/01.CIR.100.24.2406","article-title":"Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease","volume":"100","author":"Mager","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2007.07.009_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.95.1.21","article-title":"Methylenetetrahydrofolate reductase gene and coronary artery disease","volume":"95","author":"van Bockxmeer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2007.07.009_bib43","first-page":"650","article-title":"Effect of folates, vitamin B12 and lifestyle factors on mild hyperhomocysteinemia in a population sample","volume":"21","author":"Simon","year":"1999","journal-title":"Cas Lek Cesk"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907003025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907003025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:35:05Z","timestamp":1759260905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907003025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0188440907003025"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.07.009","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 677 C\/T MTHFR Polymorphism is Associated with Essential Hypertension, Coronary Artery Disease, and Higher Homocysteine Levels","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}